Trends in antiepileptic, antipsychotic, and opioid prescribing to nursing home residents with dementia

dementia
Credit: Pixabay/CC0 Public Domain

An analysis in the Journal of the American Geriatrics Society found that between 2015 and 2019, an increasing proportion of US nursing home residents with Alzheimer's Disease and related dementias (ADRD) were prescribed antiepileptics, while antipsychotic and opioid prescribing rates declined.

Also, residents with ADRD and were more likely to receive (an antiepileptic used as a mood stabilizer), while those with reported pain were more likely to receive gabapentin (an antiepileptic approved to treat nerve pain following shingles but widely prescribed for other pain conditions).

"Policy-wise, antiepileptics are flying under the radar. Because the for antiepileptics is relatively weak for both the behavioral and psychological symptoms of dementia and for most pain conditions, these prescribing trends warrant more attention," said corresponding author Molly Candon, Ph.D., of the University of Pennsylvania.

More information: Antiepileptic Prescribing to Persons Living with Dementia Residing in Nursing Homes: A Tale of Two Indications, Journal of the American Geriatrics Society (2022). DOI: 10.1111/jgs.18119

Provided by Wiley
Citation: Trends in antiepileptic, antipsychotic, and opioid prescribing to nursing home residents with dementia (2022, November 9) retrieved 2 February 2023 from https://medicalxpress.com/news/2022-11-trends-antiepileptic-antipsychotic-opioid-nursing.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Antiepileptic drugs are associated with a higher risk of mortality in persons with Alzheimer's disease

9 shares

Feedback to editors